Bruker (NASDAQ:BRKR) Hits New 12-Month High – Here’s Why

Bruker Corporation (NASDAQ:BRKR) shares reached a new 52-week high on Wednesday. The company traded as high as $65.48 and last traded at $65.25, with a volume of 222753 shares changing hands. The stock had previously closed at $64.51.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on BRKR shares. Citigroup lowered their target price on shares of Bruker from $60.00 to $53.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. The Goldman Sachs Group upgraded Bruker from a “strong sell” rating to a “strong-buy” rating in a research note on Monday, September 21st. JPMorgan Chase & Co. upped their price target on Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a report on Monday, June 8th. Zacks Research downgraded Bruker from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 2nd. Finally, Barclays raised their price objective on Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Bruker presently has a consensus rating of “Moderate Buy” and a consensus target price of $57.71.

Bruker Stock Performance

The stock’s fifty day simple moving average is $58.71 and its 200 day simple moving average is $51.20. The company has a market cap of $10.14 billion, a price-to-earnings ratio of -95.06, a P/E/G ratio of 1.94 and a beta of 1.26. The company has a current ratio of 1.85, a quick ratio of 0.92 and a debt-to-equity ratio of 0.76.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business had revenue of $838.50 million during the quarter, compared to the consensus estimate of $853.57 million. During the same quarter last year, the firm earned $0.32 EPS. The business’s revenue was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts anticipate that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, September 21st. Bruker’s payout ratio is -28.57%.

Insider Transactions at Bruker

In other Bruker news, VP Mark Munch sold 2,000 shares of the company’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total value of $105,740.00. Following the transaction, the vice president owned 134,806 shares of the company’s stock, valued at $7,127,193.22. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 27.20% of the company’s stock.

Hedge Funds Weigh In On Bruker

Several hedge funds have recently bought and sold shares of the company. Sequoia Financial Advisors LLC purchased a new stake in Bruker during the 2nd quarter worth approximately $250,000. Tidal Investments LLC boosted its position in Bruker by 180.4% in the 2nd quarter. Tidal Investments LLC now owns 29,092 shares of the medical research company’s stock valued at $1,751,000 after buying an additional 18,715 shares during the period. WINTON GROUP Ltd acquired a new position in shares of Bruker in the second quarter worth $344,000. Engineers Gate Manager LP increased its position in shares of Bruker by 141.8% during the second quarter. Engineers Gate Manager LP now owns 56,825 shares of the medical research company’s stock worth $3,420,000 after acquiring an additional 33,329 shares during the period. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of Bruker during the second quarter worth $445,000. Institutional investors and hedge funds own 79.52% of the company’s stock.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and related software used to study materials, chemicals, biological samples and industrial products. Its customers include academic and government research institutions, pharmaceutical and biotechnology companies, hospitals, environmental laboratories and industrial manufacturers.

The company’s portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray instruments, microscopy and surface-analysis platforms, molecular spectroscopy systems, and analytical tools for proteomics, spatial biology, metabolomics and materials research.